MedPath

Comparison of the efficacy of intravenous paracetamol versus intravenous dexamethasone and intravenous morphine for the emergency department treatment of acute migraine headache

Not Applicable
Conditions
Acute migraine headache.
Migraine
Registration Number
IRCT201405217327N4
Lead Sponsor
Student Research Committee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
270
Inclusion Criteria

Inclusion criteria : the patients between 18 and 60 year old without any history of neurologic disorder with at least one experience of migraine headache and 4 criteria of 12 criteria of Vascular symptoms. Exclusion criteria : pregnancy; history of neurologic disorder; patients without self consent; Body temperature more than 37.7 C; diastolic blood pressure more than 105 mm Hg.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity of the acute migrane head ache. Timepoint: Before treatment, 10 minutes after the begining of treatment, 20 minutes after the begining of the treatment, 30 minutes after the begining of the treatment, 24 hours after the begining of the treatment. Method of measurement: Visual analoge score, Intensity of the pain in proportion to millimetr from 0 to 100 will be measured.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath